@article{96b54dcc0af8459599bd39ab1a26a27c,
title = "Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword",
author = "Brian Lipworth and Rory Chan and Kuo, \{Chris RuiWen\}",
note = "Funding Information: Conflicts of interest: B. Lipworth reports nonfinancial support (equipment) from GSK; grants, personal fees (consulting, talks, and advisory board), and other support (attending ATS and ERS) from AstraZeneca; grants, personal fees (consulting, talks, and advisory board), and other support (attending ERS) from Teva; personal fees (consulting) from Lupin; personal fees (consulting) from Glenmark; personal fees (consulting) from Vectura; personal fees (consulting) from Dr. Reddy; personal fees (consulting) from Sandoz, in relation to the submitted work; and grants, personal fees (consulting, talks, and advisory board), and other support (attending BTS) from Boehringer Ingelheim; grants and personal fees (advisory board and talks) from Mylan; grants and personal fees (consulting) from Sanofi, outside of the submitted work; and the son of B. Lipworth is presently an employee of AstraZeneca. R. Chan declares no relevant conflicts of interest. C. R. Kuo reports personal fees (talks) from AstraZeneca, personal fees (advisory board) from Circassia, personal fees (talks) in relation to the submitted work, and other support from Chiesi (attending BTS) outside of the submitted work. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",
year = "2021",
month = mar,
doi = "10.1016/j.jaip.2020.12.033",
language = "English",
volume = "9",
pages = "1163--1165",
journal = "The Journal of Allergy and Clinical Immunology: In Practice",
issn = "2213-2198",
publisher = "American Academy of Allergy, Asthma and Immunology",
number = "3",
}